701 LV

Gotta say I'm amazed on how this one ended up playing out. Never thought it would be the best player in the SCS space, but I definitely thought it had room to be a niche player, that would eventually get scooped up by a major. Can someone help me decipher the 8-k filed today, that states only $10M of principal due?

Per latest 8-k. Cutting 20-25% of workforce. Expects related costs of $0.6M in Q3. Savings expected to be around $1.2M in '19 and $5.8M in '20.

Nuvectra Exploring Strategic Options to Enhance Shareholder Value Options included full sale or merger of company. Thoughts are mixed. While I fully agree this company would be better off being absorbed by a bigger player, sucks they're having to do it at these price levels. My cost average of 6's will probably never to be fully made whole - let alone the lost profits from not selling my shares at $25+ levels... Also probably means they do not think they will be able to satisfy their minimum revenue loan covenants... Overall, I guess final lesson to be learned is to always trim winners on the way up - even if you believe their LT potential is much higher, as nothing is guaranteed...

Been an absolute bloodbath the last year, especially last 6 months. Unfortunately I've ridden it all the way down. Avg cost is still in the mid 6s....Obviously in hindsight, execs jumping ship should have been a bigger red flag and shouldn't have rationalized away the concerns so easily. Now add in Virtis not being approved in '19, rep turnover and a supposed charging issue and here we are. The market has to be pricing in that they may not even hit their quarterly minimum revenue covenant of $12M. Still has $69M in cash, with a burn of $12M last Q. Also filed a $100M mixed shelf offering a few weeks back. Anyone else watching this or have any insights?

Best HSA I've found is Lively. Zero fees. Uses TD Ameritrade for investments, and you can invest every dollar - no cash holding minimum.

CEO Drees resigned unexpectedly yesterday, shares predictably down big today. Anyone hear reasons for the departure?

I'm buying more, anyone else?

I've decided to hold..I don't have anything else that I'm needing dry powder for at this time, and I still think NVTR has great long-term potential. Like you said though, it's going to depend on if there gets to be dilution concerns like there were in January and how much of a drag that puts on the stock. Biggest concern of mine is that with their success this has ballooned to be my largest position..Ha a good problem to have I suppose!

So does anyone know what follows next? Haven't been in a situation like this one before. Thanks for all the help everyone!

Just keeps on climbing. Anyone else in this name? Have a price target? I'm trying to decide if I should trim up my position at all. Currently at 5.25x/2018E Sales. Pretty close to what Nevro is trading at (5.7x) but compared to what their future numbers are projected at, there should still be tons of room to run...guess I'm just getting paranoid after watching what a runner this has been the last few months.

Any idea why the jump today? News?

New all-time high at $15.15. Another solid quarter, and continue to ramp up sales and gain market share. Still trading cheap compared to comps. 2.5x EV/2019E Sales, versus Nevro at 5.4 EV/2019E Sales. $58M cash on hand, and they burned through about $9M last quarter. I'm guessing they raise again around this time next year, but if they continue the revenue growth, should be at a higher price than we are at today.

Wow. An NDA just to be entitled to receive financials on a public company? Yikes. I'd never seen something like that before.

Announced pricing of 2.825M shares at $8.00. Shares up 5% to $8.50 after the news.

Glad to see the strong price movement the day after the dividend payment.